All Stories

  1. Pharmacy practice in hospital settings in GCC countries: Dispensing and administration

    Article • Saudi Pharmaceutical Journal, March 2023, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  2. Cost of cardiovascular diseases and renal complications in people with type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A retrospective analysis of claims database

    Article • PLoS ONE, October 2022, PLOS

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  3. Spinal muscular atrophy carrier frequency in Saudi Arabia

    Article • Molecular Genetics & Genomic Medicine, September 2022, Wiley

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  4. Effect of Occupational Stress on Pharmacists’ Job Satisfaction in Saudi Arabia

    Article • Healthcare, July 2022, MDPI AG

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  5. PB2220: MORTALITY IN PATIENTS WITH HEMOGLOBINOPATHIES AND (SARS-COV-2) COVID-19 INFECTION: SAUDI ARABIA EXPERIENCE

    Article • HemaSphere, June 2022, Wolters Kluwer Health

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  6. Introducing Saudi Journal of Clinical Pharmacy (SJCP): The official journal from the Saudi Society of Clinical Pharmacy (SSCP)

    Article • Saudi Journal of Clinical Pharmacy, January 2022, Medknow

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  7. Automation in Hospital Settings

    Article • December 2021, Taylor & Francis

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  8. Pharmacy practice in hospital settings in GCC countries: Prescribing and transcribing

    Article • Saudi Pharmaceutical Journal, September 2021, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  9. Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials

    Article • Open Forum Infectious Diseases, January 2021, Oxford University Press (OUP)

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  10. Current COVID-19 vaccine candidates: Implications in the Saudi population

    Article • Saudi Pharmaceutical Journal, December 2020, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  11. PMH24 BUDGET IMPACT ANALYSIS OF VORTIOXETINE AND/OR SERTRALINE USE FOR MANAGEMENT OF MAJOR DEPRESSIVE DISORDER IN THE KINGDOM OF SAUDI ARABIA

    Article • Value in Health, May 2020, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  12. PBI19 BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB, RISANKIZUMAB AND/OR SECUKINUMAB FOR MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE KINGDOM OF SAUDI ARABIA

    Article • Value in Health, May 2020, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  13. Clinical pharmacy practice in Saudi Arabia: Historical evolution and future perspective

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, April 2020, Wiley

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  14. PRO17 A BUDGET IMPACT ANALYSIS OF ANTI-INHIBITOR COAGULANT COMPLEX USE IN PEDIATRIC HEMOPHILIA A PATIENTS WITH INHIBITORS ACROSS KINGDOM OF SAUDI ARABIA.

    Article • Value in Health, November 2019, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  15. PGI23 COST OF INFLAMMATORY BOWEL DISEASE MANAGEMENT IN THE KINGDOM OF SAUDI ARABIA

    Article • Value in Health, November 2019, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  16. PBI4 BUDGET IMPACT ANALYSIS OF GOLIMUMAB IN ADULT RHEUMATOID ARTHRITIS PATIENTS IN KINGDOM OF SAUDI ARABIA

    Article • Value in Health, May 2019, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  17. An Evaluation of Clinical Decision Support and Use of Machine Learning to Reduce Alert Fatigue

    Article • International Journal of Computer and Communication Engineering, January 2019, International Academy Publishing (IAP)

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  18. First GCC stakeholder meeting on approval process, interchangeability/substitution and safety of biosimilars 2017 – Report

    Article • Generics and Biosimilars Initiative Journal, December 2018, Pro Pharma Communications International

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  19. Comparison of closed system transfer devices for turnaround time and ease of use

    Article • Journal of Oncology Pharmacy Practice, June 2018, SAGE Publications

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  20. Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia

    Article • Annals of Saudi Medicine, November 2017, King Faisal Specialist Hospital and Research Centre

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  21. The Revised Basel Statements on the Future of Hospital Pharmacy: What Do They Mean for Saudi Arabia?

    Article • International Journal of Pharmacy Practice, September 2017, Wiley

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai, Hanadi Al Sabban

  22. Treatment of Patients With Hepatitis C Virus infection (Genotype 4) With Ledipasvir-Sofosbuvir in the Liver Transplant Setting

    Article • Transplantation, August 2017, Wolters Kluwer Health

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  23. HBsAg clearance in chronic hepatitis B patients with add-on pegylated interferon alfa-2a to ongoing tenofovir treatment: A randomized controlled study

    Article • Saudi Journal of Gastroenterology, January 2017, Medknow

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  24. Pharmacy Practice and the Health Care System in Saudi Arabia

    Article • The Canadian Journal of Hospital Pharmacy, June 2016, Canadian Society of Hospital Pharmacists (CSHP)

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  25. Contributors

    Article • January 2016, Elsevier

    Dr Sa'ed Zyoud, Dr Abubakr A Alfadl, Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai, Abdulsalam M. Halboup

  26. Pharmacy Practice in the Kingdom of Saudi Arabia

    Article • January 2016, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  27. Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients

    Article • Canadian Journal of Gastroenterology and Hepatology, January 2016, Hindawi Publishing Corporation

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  28. A three-year study of a first-generation chemotherapy-compounding robot

    Article • American Journal of Health-System Pharmacy, May 2015, American Society of Health System Pharmacists

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  29. Introduction of vincristine mini-bags and an assessment of the subsequent risk of extravasation

    Article • Journal of Oncology Pharmacy Practice, May 2014, SAGE Publications

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  30. Hospital pharmacy practice in Saudi Arabia: Drug monitoring and patient education in the Riyadh region

    Article • Saudi Pharmaceutical Journal, October 2013, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  31. The First International Residency Program Accredited by the American Society of Health-System Pharmacists

    Article • American Journal of Pharmaceutical Education, December 2012, American Journal of Pharmaceutical Education

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  32. Hospital pharmacy practice in Saudi Arabia: Dispensing and administration in the Riyadh region

    Article • Saudi Pharmaceutical Journal, October 2012, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  33. Assessment of foetal risk associated with 93 non-US-FDA approved medications during pregnancy

    Article • Saudi Pharmaceutical Journal, October 2012, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  34. Electronic Documentation of Clinical Pharmacy Interventions in Hospitals

    Article • August 2012, IntechOpen

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  35. Hospital pharmacy practice in Saudi Arabia: Prescribing and transcribing in the Riyadh region

    Article • Saudi Pharmaceutical Journal, July 2012, Elsevier

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  36. Documenting clinical pharmacist intervention before and after the introduction of a web-based tool

    Article • International Journal of Clinical Pharmacy, January 2011, Springer Science + Business Media

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  37. Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin

    Article • Digestive Diseases and Sciences, January 2011, Springer Science + Business Media

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  38. Clinical Outcomes for Saudi and Egyptian Patients Receiving Deceased Donor Liver Transplantation in China

    Article • American Journal of Transplantation, March 2010, Wiley

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  39. Recurrence of hepatitis C virus genotype-4 infection following orthotopic liver transplantation : Natural history and predictors of outcome

    Article • Annals of Saudi Medicine, January 2009, King Faisal Specialist Hospital and Research Centre

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  40. FROM TOR TO CALCINEURIN INHIBITION: A NEW GRADED APPROACH TO STEROID WITHDRAWAL IN LOW RISK RENAL TRANSPLANT RECIPIENTS (LRRTR)

    Article • Transplantation, July 2004, Wolters Kluwer Health

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  41. A NEW APPROACH TO DESENSITIZATION OF POSITIVE T-AND B LYMPHOCYTE CROSS MATCH RECIPIENTS: KIDNEY TRANSPLANTATION ACROSS HLA BARRIERS FROM LIVING DONORS

    Article • Transplantation, July 2004, Wolters Kluwer Health

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  42. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation

    Article • Transplant Infectious Disease, September 2003, Wiley

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai

  43. Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation

    Article • Transplantation, February 2003, Wolters Kluwer Health

    Assistant Deputy Minister of Therapeutic Affairs Ahmed Aljedai